zepbound tirzepatide alternatives weight loss Eli Lilly sues companies selling alternative versions of its drug : Shots Zepbound (Tirzepatide) Injections for Weight

An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)

(2) nh gi, xem xt c nng Withaferin A Khng phi tt c withanolide u c li

10.1016/j.psyneuen.2012.11.009 31 ErregerK.DavisA

Future prospective comparative studies and large-scale real-world registries with robust control of confounding factors are warranted to define optimal treatment strategies and long-term clinical outcomes